Bifunctional antibodies and their potential clinical applications
International Journal of Clinical & Laboratory Research · 1992
DOI: 10.1007/bf02591389 ↗At a glance
Übersichtsarbeit in International Journal of Clinical & Laboratory Research, 1992. Written by O Nolan and 1 co-authors. Institution: Applied Biochemistry Group, School of Biological Sciences, Dublin City University, Glasnevin, Ireland. Cited 10 times so far (Crossref); 60 references.
Abstract (original language)
Bifunctional antibodies are monovalent, bispecific, antibody-derived molecules. They have been produced by both chemical and biological means. They are thought to have several advantages over monoclonal antibodies in both immunotherapy and immunodiagnosis. Bifunctional antibodies have been shown to be efficient in the targeting of drugs, toxins, radiolabelled haptens and effector cells on to diseased tissues, primarily cancer cells. In addition, bifunctional antibodies have been used to develop novel immunoassays. The full potential of bifunctional antibodies has yet to be realised.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Applied Biochemistry Group, School of Biological Sciences, Dublin City University, Glasnevin, Ireland.
Cite
APA
Nolan, O., & O'Kennedy, R. (1992). Bifunctional antibodies and their potential clinical applications. International Journal of Clinical & Laboratory Research. https://doi.org/10.1007/bf02591389
Vancouver
Nolan O, O'Kennedy R. Bifunctional antibodies and their potential clinical applications. International Journal of Clinical & Laboratory Research. 1992. doi:10.1007/bf02591389
BibTeX
@article{Nolan1992,
author = {Nolan, O and O'Kennedy, R},
title = {Bifunctional antibodies and their potential clinical applications},
journal = {International Journal of Clinical & Laboratory Research},
year = {1992},
doi = {10.1007/bf02591389}
}
EUVIMED